Table 3.
Analysis of coresistance to different groups of antibiotics.
|
Enterobacteria resistant to some beta-lactams antibiotics (n=123; 81.5%) |
ESBL-producers enterobacteria (n=59; 39.1%) |
Non ESBL-producers enterobacteria resistant to some beta-lactams antibiotics (n=64; 42.4%) |
Non-fermenting gram-negative bacilli resistant to fluoroquinolones (n=36; 59.0%) |
Methicillin-resistant Staphylococcus aureus (n=112) |
|
|---|---|---|---|---|---|
| Resistance to beta-lactams | - | - | - | 75.0% | - |
| Resistance to aminoglycosides | 48.8% | 47.5% | 50% | 63.9% | 79.5% |
| Resistance to fluoroquinolones | 74.0% | 74.6% | 73.4% | - | 89.3% |
| Resistance to TMX | 61.8% | 62.7% | 60.9% | - | 3.6% |
| Resistance to nitrofurantoin | 41.5% | 32.2% | 50.0% | - | - |
| Resistance to macrolides (erythromycin) | - | - | - | - | 69.6% |
| Resistance to lincosamides (clindamycin) | - | - | - | - | 49.1% |
| Resistance to rifampicin | - | - | - | - | 3.6% |
| Resistance to aminoglycosides & fluoroquinolones | 46.3% | 44.1% | 50.0% | - | 75.9% |
| Resistance to aminoglycosides & fluoroquinolones & TMX | 41.5% | 39.0% | 45.3% | - | 2.7% |
| Resistance to aminoglycosides & fluoroquinolones & TMX & nitrofurantoin | 22.8% | 22.0% | 23.4% | - | - |
| Resistance to beta-lactams & aminoglycosides | - | - | - | 55.6% | - |
| Resistance to aminoglycosides & fluoroquinolones & macrolides | - | - | - | - | 60.7% |
| Resistance to aminoglycosides & fluoroquinolones & macrolides & lincosamides | - | - | - | - | 45.5% |
TMX: Trimethoprim/sulfamethoxazole.